High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.7M
$2,674,408
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2026-03-16
$433,637x3
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2026-03-16 | $433,637x3 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
Farnum Rhonda
• Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
2025-12-03
$582,501x3
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Officer • SVP, COMM & MEDICAL AFFAIRS
10b5-1 Sell
|
2025-12-03 | $582,501x3 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
BROSHY ERAN
• Director
10b5-1 SellΔOwn -18.9%
2025-11-26
$590,020x2
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Director
10b5-1 SellΔOwn -18.9%
|
2025-11-26 | $590,020x2 | S | Form 4 |
|
TBPH
S
Theravance Biopharma, Inc.
BROSHY ERAN
• Director
10b5-1 SellΔOwn -23.2%
2025-11-11
$1,068,250Largex3
|
||||||
| TBPH |
Theravance Biopharma, Inc.
|
Director
10b5-1 SellΔOwn -23.2%
|
2025-11-11 | $1,068,250Largex3 | S | Form 4 |